Edward M Cox
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Viral Infections and Outbreaks Research 3
- Tuberculosis Research and Epidemiology 1
- HIV/AIDS Research and Interventions 1
-
- Antibiotic Use and Resistance 2
- Co-authors
- Debra B. Birnkrant (1 shared paper)Luciana L. Borio (4 shared papers)Sumathi Nambiar (4 shared papers)Robert Temple (2 shared papers)John J Farley (3 shared papers)Lindsey Robert Baden (1 shared paper)Joseph G. Toerner (1 shared paper)Michael L. Lanthier (1 shared paper)
- Journals
- New England Journal of Medicine (5 papers)Clinical Infectious Diseases (3 papers)The American Journal of Bioethics (1 paper)Drug Safety (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomUganda
In The Last Decade
Edward M Cox
19 papers receiving 5.5k citations
Edward M Cox's Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Medicine 1.4k
- Applied Microbiology and Biotechnology 151
- Microbiology 222
- Infectious Diseases 297
- Food Science 205
Countries citing papers authored by Edward M Cox
This map shows the geographic impact of Edward M Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M Cox more than expected).
Fields of papers citing papers by Edward M Cox
This network shows the impact of papers produced by Edward M Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M Cox. The network helps show where Edward M Cox may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward M Cox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Hit paper breakdown → | 2017 | 4975 |
| 2 | 2014 | 161 | |
| 3 | 2009 | 159 | |
| 4 | 2014 | 62 | |
| 5 | 2020 | 48 | |
| 6 | 2014 | 47 | |
| 7 | 2006 | 42 | |
| 8 | 2012 | 34 | |
| 9 | 2019 | 34 | |
| 10 | 2018 | 25 | |
| 11 | 2015 | 24 | |
| 12 | 2018 | 14 | |
| 13 | 2008 | 10 | |
| 14 | 2020 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2015 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2017 | 2 |
About Edward M Cox
Edward M Cox is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Analytical Chemistry, Statistics and Probability and Epidemiology, having authored 19 papers that have together received 5.7k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (3 papers), Antibiotic Use and Resistance (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Tuberculosis Research and Epidemiology (1 paper), HIV/AIDS Research and Interventions (1 paper), Pneumonia and Respiratory Infections (1 paper), Statistical Methods in Clinical Trials (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Molecular Medicine (1.4k citations), Applied Microbiology and Biotechnology (151 citations), Microbiology (222 citations), Infectious Diseases (297 citations) and Food Science (205 citations). Edward M Cox has collaborated with scholars based in United States, United Kingdom and Uganda. Frequent co-authors include Debra B. Birnkrant, Luciana L. Borio, Sumathi Nambiar, Robert Temple, John J Farley, Lindsey Robert Baden, Joseph G. Toerner, Michael L. Lanthier, Nicole M. Mahoney and Nicole Lurie. Their work appears in journals such as New England Journal of Medicine, Clinical Infectious Diseases, The American Journal of Bioethics, Drug Safety and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.